Online inquiry

IVTScrip™ mRNA-Human ANKRD10, (Cap 0, Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK16397MR)

This product GTTS-WK16397MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & Pseudo-UTP. It ecodes the ANKRD10 protein. This product can be used in Exhausted CD8+ T cell-related researches.
Specifications
Product type mRNA
Modified bases Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001286721.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 55608
UniProt ID Q9NXR5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD10, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK16397MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK5102MR IVTScrip™ mRNA-Human Synaptophysin, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Synaptophysin
GTTS-WK14046MR IVTScrip™ mRNA-Human ADGRL2, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADGRL2
GTTS-WK24443MR IVTScrip™ mRNA-Human ARL4D, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARL4D
GTTS-WK27110MR IVTScrip™ mRNA-Human ARHGEF16, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF16
GTTS-WK14330MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK15229MR IVTScrip™ mRNA-Human ANKRD49, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD49
GTTS-WK19437MR IVTScrip™ mRNA-Human ANKRD9, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD9
GTTS-WK3912MR IVTScrip™ mRNA-Human CYR61, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CYR61
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →